 | | | | Two former managers of French meat-processing firm Spanghero and two Dutch meat traders go on trial in Paris on Monday accused of passing off cheap horse meat as pricier beef in ready-made meals and burgers that were sold in countries across Europe. | | | | | | A Chinese scientist responsible for what he said were the world's first "gene-edited" babies evaded oversight and broke guidelines in a quest for fame and fortune, state media said on Monday, as the university where he worked announced his dismissal. | | | | | | China's agriculture ministry on Sunday reported a new African swine fever outbreak in the northwestern region of Ningxia. | | | | | | (Reuters Health) - In many cases, veterans get a first appointment at VA hospitals quicker than the general public gets first appointments with health care providers, government researchers report. | | | | | | AbbVie Inc said on Friday its blockbuster cancer treatment in combination with chemotherapy agents failed to meet the main goal in a late-stage study of patients with a form of pancreatic cancer. | | | | | | (Reuters Health) - Older adults who have exercised regularly for at least a year may be less likely to experience falls or related injuries than their less active peers, a research review suggests. | | | | | | (Reuters Health) - Women going through menopause may have fewer symptoms of depression when they get treatment for insomnia than when they don't, a recent experiment suggests. | | | | | | The U.S. Food and Drug Administration said on Friday it had approved a biosimilar to Roche Holding AG's blockbuster breast cancer treatment, Herceptin. | | | | | | (Reuters Health) - When people with heart failure are hospitalized, having influenza is tied to greater odds of respiratory and kidney complications and a higher chance they won't survive to be discharged, a U.S. study suggests. | | | | | | Eli Lilly and Co said on Friday that its cancer treatment Lartruvo, which had won conditional approval, failed to improve patient survival in a long-term confirmatory study and will no longer be prescribed, driving the drugmaker's shares down nearly 3 percent. | | | | | | (Reuters Health) - Researchers are reporting a link between doctor-targeted marketing of opioid products and the increase in U.S. deaths from overdoses. | | | | | |
